Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

ClinicalTrials.gov ID: NCT00082381

Public ClinicalTrials.gov record NCT00082381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of AC2993 (Synthetic Exendin-4) Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, comparator-controlled, open-label, randomized, two-arm, parallel trial to compare the effect of exenatide twice daily and insulin glargine on glycemic control, as measured by hemoglobin A1c (HbA1c).

Study identification

NCT ID
NCT00082381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
551 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Apr 7, 2015

2003 – 2008

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Radiant Research-San Diego San Diego California 92108 —
Dorothy L. and James E. Frank Diabetes Research Institute San Mateo California 94401 —
Internal Medicine Associates Department of Research Fort Myers Florida 33901 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Baptist Diabetes Associates Miami Florida 33176 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Springfield Diabetes & Endocrine Center Springfield Illinois 62704 —
Frederick Primary Care Associates Frederick Maryland 21702 —
Radiant Research, Inc. St Louis Missouri 63141 —
Lovelace Scientific Resources, Inc. Las Vegas Nevada 89102 —
Diabetes, Endocrine & Nutrition Hampton New Hampshire 03842 —
Lovelace Scientific Resources Albuquerque New Mexico 87108 —
Great Lakes Medical Research Westfield New York 14787 —
DOCS, Beth Israel Medical Center Yonkers New York 10710 —
Piedmont Medical Research Associates Winston-Salem North Carolina 27103 —
Jon Shapiro, MD Philadelphia Pennsylvania 19146 —
Endocrinology Consultants of East Tennessee Knoxville Tennessee 37909 —
Israel Hartman, MD Arlington Texas 76014 —
Diabetes & Glandular Research Associates, P.A. San Antonio Texas 78229 —
Jack Wahlen, MD Ogden Utah 84403 —
Rainier Clinical Research Center, Inc. Renton Washington 98055 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00082381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2015 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00082381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →